GlobalData's clinical trial report, "Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2012" provides data on the Alpha- Antitrypsin Deficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alpha- Antitrypsin Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Alpha- Antitrypsin Deficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Alpha- Antitrypsin Deficiency Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Alpha- Antitrypsin Deficiency, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Alpha- Antitrypsin Deficiency
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Alpha- Antitrypsin Deficiency
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Baxter International Inc.
Clinical Trial Overview of Baxter International Inc.
Grifols, S.A.
Clinical Trial Overview of Grifols, S.A.
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
Kamada Ltd.
Clinical Trial Overview of Kamada Ltd.
CSL Limited
Clinical Trial Overview of CSL Limited
Bayer AG
Clinical Trial Overview of Bayer AG
Clinical Trial Overview of Top Universities / Institutes / Hospitals
Medical University of South Carolina
Clinical Trial Overview of Medical University of South Carolina
University of Florida
Clinical Trial Overview of University of Florida
University of Massachusetts
Clinical Trial Overview of University of Massachusetts
Klinikum Berchtesgadener Land der Schon-Kliniken
Clinical Trial Overview of Klinikum Berchtesgadener Land der Schon-Kliniken
Hospices Civils de Lyon
Clinical Trial Overview of Hospices Civils de Lyon
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
University of Pittsburgh
Clinical Trial Overview of University of Pittsburgh
Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2012 published by GlobalData in July 24, 2012. This report consists of Pages: 70 and the price starts from US $ 2500.
The contents of this page may be different from the latest version. Please contact us for details.
